JP5207969B2 - 巨大環状のキレート化剤によるビオチンジアミノ誘導体およびその複合体 - Google Patents

巨大環状のキレート化剤によるビオチンジアミノ誘導体およびその複合体 Download PDF

Info

Publication number
JP5207969B2
JP5207969B2 JP2008532721A JP2008532721A JP5207969B2 JP 5207969 B2 JP5207969 B2 JP 5207969B2 JP 2008532721 A JP2008532721 A JP 2008532721A JP 2008532721 A JP2008532721 A JP 2008532721A JP 5207969 B2 JP5207969 B2 JP 5207969B2
Authority
JP
Japan
Prior art keywords
group
integer
complex
compound
nhr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008532721A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009510009A (ja
Inventor
パオロ・カルミナティ
マウロ・ジナンネスキ
ジョヴァンニ・パガネッリ
マルコ・キノル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JP2009510009A publication Critical patent/JP2009510009A/ja
Application granted granted Critical
Publication of JP5207969B2 publication Critical patent/JP5207969B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0495—Pretargeting

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Polyethers (AREA)
JP2008532721A 2005-09-27 2006-09-18 巨大環状のキレート化剤によるビオチンジアミノ誘導体およびその複合体 Expired - Fee Related JP5207969B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05021034 2005-09-27
EP05021034.3 2005-09-27
PCT/EP2006/066440 WO2007039437A1 (en) 2005-09-27 2006-09-18 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents

Publications (2)

Publication Number Publication Date
JP2009510009A JP2009510009A (ja) 2009-03-12
JP5207969B2 true JP5207969B2 (ja) 2013-06-12

Family

ID=35825361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532721A Expired - Fee Related JP5207969B2 (ja) 2005-09-27 2006-09-18 巨大環状のキレート化剤によるビオチンジアミノ誘導体およびその複合体

Country Status (24)

Country Link
US (1) US7816388B2 (zh)
EP (1) EP1928508B1 (zh)
JP (1) JP5207969B2 (zh)
KR (1) KR101301549B1 (zh)
CN (1) CN101272809B (zh)
AR (1) AR056201A1 (zh)
AT (1) ATE447977T1 (zh)
AU (1) AU2006298827B2 (zh)
BR (1) BRPI0616441B8 (zh)
CA (1) CA2621960C (zh)
CY (1) CY1109836T1 (zh)
DE (1) DE602006010413D1 (zh)
DK (1) DK1928508T3 (zh)
EA (1) EA200800948A1 (zh)
ES (1) ES2335609T3 (zh)
HK (1) HK1125036A1 (zh)
HR (1) HRP20100071T1 (zh)
ME (1) ME01845B (zh)
PL (1) PL1928508T3 (zh)
PT (1) PT1928508E (zh)
RS (1) RS51254B (zh)
SI (1) SI1928508T1 (zh)
TW (1) TWI381852B (zh)
WO (1) WO2007039437A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543342B1 (ko) * 2002-06-28 2006-01-20 한국 한의학 연구원 뇌신경세포의 손상을 치료하기 위한 한약재 조성물
JP5263805B2 (ja) * 2007-06-13 2013-08-14 国立大学法人群馬大学 両親媒性の高分子配位子によって安定化された高分子錯体および検査用組成物および医薬組成物
GB0922369D0 (en) * 2009-12-22 2010-02-03 Hammersmith Imanet Ltd Labelled biotin conjugates
BR112013009614A2 (pt) * 2010-10-22 2016-07-19 Centre Nat Rech Scient conjugados de pochoxime úteis para o tratamento de patologias relacionadas à hsp90
WO2023240135A2 (en) 2022-06-07 2023-12-14 Actinium Pharmaceuticals, Inc. Bifunctional chelators and conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283342A (en) 1992-06-09 1994-02-01 Neorx Corporation Biotinylated small molecules
EP1138334A3 (en) 1992-06-09 2002-04-03 Neorx Corporation Pretargeting methods and compounds
US5911969A (en) * 1992-06-09 1999-06-15 Neorx Corporation Pretargeting protocols for enhanced localization of active agents to target sites
US6120768A (en) * 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives
US5955605A (en) 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
ITRM20010079A1 (it) * 2001-02-16 2002-08-16 Sigma Tau Ind Farmaceuti Amminoderivati della biotina e loro coniugati con chelanti macrociclici.

Also Published As

Publication number Publication date
TWI381852B (zh) 2013-01-11
HRP20100071T1 (hr) 2010-03-31
TW200744647A (en) 2007-12-16
PL1928508T3 (pl) 2010-04-30
RS51254B (sr) 2010-12-31
ES2335609T3 (es) 2010-03-30
BRPI0616441A2 (pt) 2011-06-21
BRPI0616441B8 (pt) 2021-05-25
HK1125036A1 (en) 2009-07-31
CA2621960A1 (en) 2007-04-12
CY1109836T1 (el) 2014-09-10
ME01845B (me) 2010-12-31
WO2007039437A1 (en) 2007-04-12
EP1928508A1 (en) 2008-06-11
PT1928508E (pt) 2010-01-28
ATE447977T1 (de) 2009-11-15
US7816388B2 (en) 2010-10-19
JP2009510009A (ja) 2009-03-12
EA013130B1 (ru) 2010-02-26
KR20080059159A (ko) 2008-06-26
CA2621960C (en) 2015-09-15
AU2006298827B2 (en) 2011-02-03
BRPI0616441B1 (pt) 2019-07-02
AU2006298827A1 (en) 2007-04-12
DE602006010413D1 (de) 2009-12-24
KR101301549B1 (ko) 2013-09-04
EA200800948A1 (ru) 2010-02-26
CN101272809B (zh) 2011-01-26
SI1928508T1 (sl) 2010-03-31
AR056201A1 (es) 2007-09-26
EP1928508B1 (en) 2009-11-11
US20080249152A1 (en) 2008-10-09
CN101272809A (zh) 2008-09-24
DK1928508T3 (da) 2010-03-29

Similar Documents

Publication Publication Date Title
JP4236282B2 (ja) 部位特異的ターゲッティング用の放射性標識ペプチド組成物
US8044081B2 (en) Aminoderivative of biotin and their conjugates with macrocyclic chelating agents
JP5207969B2 (ja) 巨大環状のキレート化剤によるビオチンジアミノ誘導体およびその複合体
AU2002237517A1 (en) Biotin-derivatives and their conjugates with chelating agents
WO2021175147A1 (zh) 前列腺特异性膜抗原结合配体偶联物及其应用
WO1997010854A1 (en) (radio) labelled biotin derivatives
CA2436242C (en) Biotin-derivatives and their conjugates with chelating agents
JPH09512251A (ja) 金属含有ステロイド模擬体およびその製造に有用なリガンド
EP1913959A1 (en) Radioactive metal complexes comprising a tridentate complexing sequence
Pollack et al. Hydrazino-type N 2 S 2 chelators

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090903

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120501

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120806

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120911

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121210

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130122

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130219

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160301

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5207969

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees